Skip to main content

Table 5 CMR findings EGPA

From: T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides

 

Controls (n = 20)

Patients (n = 22)

p

LV-EF (%)

65 ± 4

62 ± 12

0.58

LV-EDV (ml)

109 ± 27

124 ± 48

0.38

LV-ESV (ml)

38 ± 13

51 ± 37

0.35

LV-SV

71 ± 15

74 ± 17

0.76

LV-EDD

45 ± 5

48 ± 6

0.06

LA (cm2)

20 ± 3

21 ± 6

0.97

IVS (mm)

10 ± 2

10 ± 2

0.23

PA (mm)

24 ± 4

25 ± 3

0.27

LV mass (g)

85 ± 20

89 ± 25

0.83

LGE per patient

-

9 (41%)

 

epicardial

-

3 (14%)

 

intramural

-

2 (9%)

 

transmural

-

-

 

subendocardial

-

4 (18%)

 

% LV mass

-

7.1 ± 6

 

Native T1 (ms)

952 (923–960)

982 (958–1007)

0.003

Post-contrast T1 (ms)

524 (500–529)

481 (462–527)

0.02

ECV (%)

24.5 (23–25)

28 (25–31)

<0.001

T2 (ms)

49 (48–51)

53 (50–55)

<0.001

  1. All values are n or mean ± SD or interquartile ranges. CMR cardiac magnetic resonance, LV left-ventricular, EF ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, EDD end-diastolic diameter, LA left atrium, IVS interventricular septum, PA pulmonary artery, LGE late gadolinium enhancement, ECV extracellular volume
Back to article page

Journal of Cardiovascular Magnetic Resonance

ISSN: 1532-429X

Contact us